The Weill Cornell Medicine (WCM) SPORE consists of four Projects focused on highly translational areas relevant to the detection and treatment of aggressive prostate cancer (PCa).

Projects 1, 2, and 4 build on first-in-class discoveries made by study co-leaders that are fostered with significant preliminary data. Project 3 builds on highly collaborative interactions with multiple SPORE groups, using state-of-the-art genomics in a Clinical Laboratory Improvement Amendments (CLIA) setting.

PROJECTS: Project 1Project 2Project 3Project 4 

  • Develop accurate biomarkers to assess the risk of PCa disease progression 
  • Develop new therapeutic approaches for clinically localized and CRPC that are hypothesis-driven 
  • Leverage existing and expand new infrastructure for the successful translation of pre-clinical studies into the clinic
  • Train the next generation of PCa investigators through the CEP and DRP

Weill Cornell Medicine SPORE in Prostate Cancer Belfer Research Building
413 E. 69th St.
New York, NY 10021 Phone: (646) 962-6184